Related Experiment Video
Updated: Jun 15, 2026

Transuterine Fetal Tracheal Occlusion Model in Mice
Published on: February 5, 2021
Gestational Age and Birthweight Predict Airflow Obstruction: A Study from the Swedish National Airway Register
Maria Ödling1,2, Mikael Andersson Franko1, Helena Backman3
1Department of Clinical Science and Education, Södersjukhuset, and.
Insights
Gestational age (GA) is a key predictor of persistent airflow obstruction in individuals with asthma or COPD up to age 49. Birthweight adjusted for GA also impacts obstruction risk, highlighting the importance of perinatal factors.
Area of Science:
- Pulmonary Medicine
- Perinatal Research
- Epidemiology
Background:
- Limited research exists on perinatal factors influencing airflow obstruction into middle adulthood.
- Understanding these early-life influences is crucial for managing chronic respiratory diseases.
Purpose of the Study:
- To examine the association between gestational age (GA), GA-adjusted birthweight, mode of delivery, and persistent airflow obstruction.
- To investigate these links in individuals aged 7-49 with obstructive lung diseases like asthma and COPD.
Main Methods:
- Analysis of 44,778 individuals from the Swedish National Airway Register (2014-2022) and Medical Birth Register (1973-2015).
- Inclusion criteria: asthma or COPD diagnosis, post-bronchodilator FEV1 and FVC measurements, and available GA and birthweight data.
- Persistent airflow obstruction defined as FEV1/FVC z-score below the lower limit of normal.
Main Results:
- Preterm birth (all categories) was associated with increased odds of persistent airflow obstruction up to age 49.
- Middle-aged adults born small for GA had higher odds of obstruction (OR, 1.49).
- Gestational age was the most significant covariate; GA-adjusted birthweight improved prediction for late preterm, term, and postterm births.
Conclusions:
- Gestational age is an independent and primary covariate for persistent airflow obstruction in asthma and COPD patients across all age groups.
- GA-adjusted birthweight further refines the prediction of airflow obstruction risk.
Abstract:
Rationale: Few studies have identified risk sets for perinatal factors and airflow obstruction into middle adulthood. Objectives: To investigate associations between gestational age (GA), GA-adjusted birthweight, and mode of delivery and persistent airflow obstruction among patients 7-49 years old with obstructive lung diseases. Methods: The study population encompassed 44,778 individuals with asthma or chronic obstructive pulmonary disease (COPD) and one or more registration of post-bronchodilator values of forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) recorded in the Swedish National Airway Register in 2014-2022 and with both GA and birthweight data in the Medical Birth Register between 1973-2015. Persistent airflow obstruction was defined as a FEV1/FVC z-score below the lower limit of normal. Analyses were done separately for children, young adults, and middle-aged adults. Results: Subjects who were extremely, very, moderate, and late preterm-born all had increased odds ratios (ORs) of persistent airflow obstruction up to age 49 years compared with those term-born. Middle-aged adults born small for GA had increased OR of persistent airflow obstruction compared with those appropriate for GA (OR, 1.49; 95% confidence interval, 1.23-1.81). In the risk sets, GA was the most significant covariate for persistent airflow obstruction. GA-adjusted birthweight was an additional covariate for those born late preterm, term, or postterm. Mode of delivery did not contribute. Conclusions: GA was an independent covariate of persistent airflow obstruction and, in the risk sets, proved to be the most important covariate in patients of all ages with either asthma or COPD. GA-adjusted birthweight further improved the prediction.
More Related Videos
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Factors Affecting Pulmonary Ventilation
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Assessment of Airway, Skin Color, and Use of Accessory Muscles
Introduction
The initial evaluation of a patient's respiratory system...
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Breathing
Respiratory Volumes
Tidal Volume (TV) Tidal volume (TV) is the air inhaled or exhaled in a...